West Pharmaceutical Services (WST) Amortizatization of Intangibles (2009 - 2026)

West Pharmaceutical Services (WST) has reported Amortizatization of Intangibles for 18 consecutive years, with $500000.0 the latest figure, recorded in Q2 2026.

• Quarterly Amortizatization of Intangibles fell 16.67% year-over-year to $500000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.4 million (down 27.27% YoY) and the FY2025 annual result came in at $2.8 million, down 22.22% from the prior year.
• Amortizatization of Intangibles eased to $500000.0 in Q2 2026 per WST's latest filing, from $600000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for WST reached as high as $1.3 million in Q4 2023 and fell as low as $500000.0 in Q2 2023.
• A 5-year average of $822222.2 and a median of $900000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 52.38% — and 2024, when it jumped 80.0%.
• Year by year, Amortizatization of Intangibles stood at $1.0 million in 2022, then advanced by 30.0% to $1.3 million in 2023, then plunged by 30.77% to $900000.0 in 2024, then sank by 33.33% to $600000.0 in 2025, then slipped by 16.67% to $500000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $500000.0, $600000.0, and $600000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.